Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis
Open Access
- 6 October 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (R2), R156-R162
- https://doi.org/10.1093/hmg/ddp303
Abstract
Amyotrophic lateral sclerosis (ALS) is the most common adult motor neuron disease that affects ∼2/100 000 individuals each year worldwide. Patients with ALS suffer from rapidly progressive degeneration of motor neurons ultimately leading to death. The major pathological features observed in post-mortem tissue from patients with ALS are motor neuron loss, cortical spinal tract degeneration, gliosis and cytoplasmic neuronal inclusions formed by TDP-43 or TAR DNA binding Protein with a molecular mass of 43 kDa, which are now recognized as the signature lesions of sporadic ALS. TDP-43 possesses two RNA binding domains (RBD) and a glycine-rich C terminus classifying it with other heterogeneous nuclear ribonucleoproteins known as 2XRBD-Gly proteins. A number of reports showed that a subset of patients with ALS possess mutations in the TDP-43 (TARDBP) gene. This further strengthens the hypotheses that gain of toxic function or loss of function in TDP-43 causes ALS. Currently, 29 different TARDBP missense mutations have been reported in 51 unrelated sporadic or familial ALS cases and two cases of ALS plus concomitant frontotemporal lobar degeneration with a remarkable concentration of mutations in the C-terminal glycine-rich domain of TDP-43. As these mutations will most certainly be an invaluable tool for the design and implementation of ALS animal and cell models, as well as serve as a platform for exploring the pathobiology of TDP-43, here we summarize the identified pathogenic TARDBP mutations and their potential impact on our understanding of the role of TDP-43 in disease.Keywords
This publication has 66 references indexed in Scilit:
- Rethinking ALS: The FUS about TDP-43Cell, 2009
- Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseasesZeitschrift für Neurologie, 2009
- Clinical and Pathological Continuum of Multisystem TDP-43 ProteinopathiesArchives of Neurology, 2009
- Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathiesActa Neuropathologica, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- Two German Kindreds With Familial Amyotrophic Lateral Sclerosis Due to TARDBP MutationsArchives of Neurology, 2008
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisThe Lancet Neurology, 2008
- A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitroFEBS Letters, 2008
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993